Maryellen McQuade serves as the Chief Talent & Sustainability Officer at Biohaven Pharmaceuticals, where she plays a pivotal role in shaping the company’s human resources strategy during a transformative period marked by rapid growth and significant acquisitions. With Biohaven's workforce expanding to nearly 1,200 employees...
Maryellen McQuade serves as the Chief Talent & Sustainability Officer at Biohaven Pharmaceuticals, where she plays a pivotal role in shaping the company’s human resources strategy during a transformative period marked by rapid growth and significant acquisitions. With Biohaven's workforce expanding to nearly 1,200 employees following the October 2022 acquisition of the CGRP franchise, Maryellen is at the forefront of integrating diverse talent pools and fostering a culture of innovation and inclusion. Her expertise in operating model transformations and change management is instrumental as the organization charts a new course toward building a best-in-class drug discovery engine.
In her current role, Maryellen collaborates closely with scientific and commercial leaders to ensure that talent management strategies align with Biohaven’s ambitious goals. She is actively involved in identifying and recruiting top-tier talent, leveraging her extensive experience in organizational design and leadership development to create a dynamic and engaged workforce. Maryellen’s commitment to employee relations and organizational development not only enhances team performance but also drives the company’s sustainability initiatives, ensuring that Biohaven remains a leader in both pharmaceutical innovation and corporate responsibility.
Her strategic vision encompasses the integration of diversity and inclusion principles across all levels of the organization, recognizing that a diverse workforce is essential for fostering creativity and driving business success. As a seasoned HR consultant, Maryellen’s ability to navigate the complexities of mergers and acquisitions, coupled with her skills in executive coaching and deferred compensation strategies, positions her as a key architect of Biohaven’s future growth and sustainability efforts. Through her leadership, Biohaven is poised to not only advance its scientific mission but also cultivate a thriving workplace culture that attracts and retains top talent.
